<DOC>
	<DOCNO>NCT00194545</DOCNO>
	<brief_summary>Following significant reduction antiretroviral drug price past two year , HIV-1 infect African adult child gain access treatment . However , due complex drug regimens take continuously , suboptimal adherence likely formidable challenge . As program provide antiretroviral drug Africa scale , achievement excellent adherence high priority result maximum benefit drug forestall development resistant virus . A good understanding predictor pediatric HAART adherence African child essential order formulate feasible , culturally appropriate , strategy monitor enhance adherence . There also urgent need evaluate simple , inexpensive intervention widely applicable African setting . The medication diary use empirically among HIV infect adult child Western country , mainly tool monitor less extent improve HAART adherence . Literacy level rise significantly African region past year , diary also modify use picture suit parent different literacy level . We propose conduct randomize control trial determine effect medication diary counsel versus counsel alone HAART-adherence HIV-1 infect child parents/caregivers Nairobi Kenya .</brief_summary>
	<brief_title>Effect Medication Diaries Adherence Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children</brief_title>
	<detailed_description>Study design : This randomized trial compare adherence antiretroviral drug clinical outcome 50 HIV-1 infect Kenyan child randomize simple medication diary plus standard counseling similar group child randomize counsel alone . Study procedure : Parents caregiver HIV-1 infect child discharge Kenyatta National Hospital ( KNH ) child 's ward see pediatric outpatient clinic invite participate study nurse counselor . Informed write consent obtain meet eligibility criterion agree participate . The consent process do principal investigator confidential area . A baseline questionnaire administer obtain socio-demographic information previous medical history parents/caregiver child . All enrol undergo three session counsel conduct trained nurse counselor regard antiretroviral therapy two-week period . After successful completion counsel process , 8 ml blood drawn child liver function test , urea , blood count include hemoglobin , CD4 cell count HIV-1 viral load . After receive result laboratory test , child randomize two group . Those first group give medication diary caregiver record child 's daily intake antiretroviral drug . Those second group follow without diary . Children group start three antiretroviral drug : zidovudine , nevirapine , lamivudine . Caregivers request bring next clinic appointment drug container past month 's prescription . Those intervention arm request carry medication diary appointment . Follow-up : Clinic appointment plan 2 week initiate antiretroviral therapy monthly interval thereafter . At visit , adherence monitor use self report use pediatric adherence questionnaire . Pill count perform 3-monthly interval . A study nurse review medication diary parent/caregiver intervention study arm , address issue raise diary use . At 3,6 , 9 month initiation antiretroviral therapy , 8 ml blood drawn child liver function test , urea , blood count include hemoglobin , CD4 cell count HIV-1 viral load , antiretroviral drug resistance . In-depth interview conduct caregiver cover broad range experience . The second two aim study summarize : Aim 2 ) : Define correlate adherence measure self report specific component pediatric HAART regimen HIV-1 infect child initiate therapy Nairobi , Kenya . Aim 3 ) Identify behavioral social problem experience caregiver relation paediatric HAART adherence define mechanism improve adherence .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>parents/caregivers plan reside Nairobi least one year initiation antiretroviral therapy HIV1 infect child age 18 month 12 year symptomatic disease ( WHO stage II III ) and/or CD4 &lt; 20 % [ CD4 count available ] previous use antiretroviral drug child apart drug take part prevention mother child transmission HIV child endstage AIDS include widespread disseminated malignancy , generalize severe encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>pediatric adherence</keyword>
	<keyword>medication diary</keyword>
	<keyword>HAART</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>